CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
about
Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner.Gene expression signatures differentiate uterine endometrial stromal sarcoma from leiomyosarcomaInconsistent results in the analysis of ALK rearrangements in non-small cell lung cancerA proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma.The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?Downregulation of CD99 and upregulation of human leukocyte antigen class II promote tumor aggravation and poor survival in patients with osteosarcomas.Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells.The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signalingReaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.si-RNA-mediated knockdown of PDLIM5 suppresses gastric cancer cell proliferation in vitro.CD99 is upregulated in placenta and astrocytomas with a differential subcellular distribution according to the malignancy stage.The crucial role of emilin 1 gene expression during progression of tumor growth.Bayesian logistic regression in detection of gene-steroid interaction for cancer at PDLIM5 locus.Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.Targeted development of specific biomarkers of endometrial stromal cell differentiation using bioinformatics: the IFITM1 model.High expression of PDLIM5 facilitates cell tumorigenesis and migration by maintaining AMPK activation in prostate cancer.CD99 at the crossroads of physiology and pathology.The potential clinical impact of the tissue-based map of the human proteome.Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.Targeting the tumour stroma to improve cancer therapy.CD99: A Cell Surface Protein with an Oncojanus Role in Tumors.Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network.Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancerDiagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
P2860
Q33635277-2C8F58D4-158F-4681-A765-A6361D99513BQ33732473-3B57EB34-0EBB-4514-B254-ADDA909EC0D7Q36096398-498C4A95-778F-4C5A-ACF9-6A1D91D2C488Q36662001-734BBCAC-65A7-4E64-B871-A7710034C5E3Q38328376-FD5D95A7-517E-4339-98F7-2D4A0DAD770FQ38553340-48D3DD8A-1A05-48ED-AFA9-09DFCD6D7FC2Q38661469-E0F2172F-226F-4EC8-9748-DED527BAFE21Q38809268-56BE20EF-D2DB-4956-89C3-5F5362AEA6CCQ38915283-1DAEDF53-2891-4970-B34E-3FA06F96214FQ38957205-3A0B2415-7140-450E-A062-E86D0D653D84Q38998414-79AE1224-604D-4707-A9E0-BA609B5A4DFBQ40401673-0D678272-637E-497A-9D6E-6FFE5654F014Q40678971-4A61C9D3-20C8-4ACB-A969-F743C90C420AQ41125664-6C10C349-706E-44F1-9570-E0B40458F3C0Q45199929-F814F03C-ECD8-47B0-8F72-2A2B326DD254Q47097189-F5AEE908-EE5C-4875-8DBA-E89E90D8436EQ47203268-7D2100CF-A526-4E0F-91D7-0A01EC479EF2Q48495415-A4BDB05B-7603-4A0D-ADE8-7A6CC6EB8CE4Q50133270-99B5E89D-229D-4425-A07D-D663CD605D9FQ52322982-CD28F8A8-8929-4929-A266-771998DA8366Q52658031-4AD5B28C-F27A-4B01-8D77-03DFA500DE15Q55346557-F6A6DFF9-3585-459A-80DE-C86A99C2F3E2Q57221375-F57273DE-AFD0-4878-B2CF-8BEAD1F6DBC0Q58725269-082E151E-C87F-49E7-8BA9-BB95E1F8B2C6
P2860
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@ast
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@en
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@nl
type
label
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@ast
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@en
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@nl
prefLabel
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@ast
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@en
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@nl
P2093
P2860
P50
P356
P1476
CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
@en
P2093
Akira Saito
Anders Berglund
Anders Isaksson
Arne Ostman
Fredrik Nyberg
Hanna Göransson-Kultima
Johan Botling
Karolina Edlund
Kristina Lamberg
Leif Johansson
P2860
P304
P356
10.1002/IJC.27518
P577
2012-04-24T00:00:00Z